TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX

TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX

The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PERSSON, Bo-Eric, CANTOR, Per, OLESEN, Tine Kold, VAN DER MEULEN, Egbert, A, JENSEN, Jens-Kristian Slott
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PERSSON, Bo-Eric
CANTOR, Per
OLESEN, Tine Kold
VAN DER MEULEN, Egbert, A
JENSEN, Jens-Kristian Slott
description The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4257197A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4257197A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4257197A23</originalsourceid><addsrcrecordid>eNrjZLAJCXJ1DPF19QtR8HdT8HUNcQwOcQzxdFYAUu6uCgFB_iC-q4Kzo5-za5BCuGeIh4KLq7tjkKuPZwQPA2taYk5xKi-U5mZQcHMNcfbQTS3Ij08tLkhMTs1LLYl3DTAxMjU3tDR3NDImQgkAwh0pTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX</title><source>esp@cenet</source><creator>PERSSON, Bo-Eric ; CANTOR, Per ; OLESEN, Tine Kold ; VAN DER MEULEN, Egbert, A ; JENSEN, Jens-Kristian Slott</creator><creatorcontrib>PERSSON, Bo-Eric ; CANTOR, Per ; OLESEN, Tine Kold ; VAN DER MEULEN, Egbert, A ; JENSEN, Jens-Kristian Slott</creatorcontrib><description>The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231011&amp;DB=EPODOC&amp;CC=EP&amp;NR=4257197A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231011&amp;DB=EPODOC&amp;CC=EP&amp;NR=4257197A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PERSSON, Bo-Eric</creatorcontrib><creatorcontrib>CANTOR, Per</creatorcontrib><creatorcontrib>OLESEN, Tine Kold</creatorcontrib><creatorcontrib>VAN DER MEULEN, Egbert, A</creatorcontrib><creatorcontrib>JENSEN, Jens-Kristian Slott</creatorcontrib><title>TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX</title><description>The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAJCXJ1DPF19QtR8HdT8HUNcQwOcQzxdFYAUu6uCgFB_iC-q4Kzo5-za5BCuGeIh4KLq7tjkKuPZwQPA2taYk5xKi-U5mZQcHMNcfbQTS3Ij08tLkhMTs1LLYl3DTAxMjU3tDR3NDImQgkAwh0pTg</recordid><startdate>20231011</startdate><enddate>20231011</enddate><creator>PERSSON, Bo-Eric</creator><creator>CANTOR, Per</creator><creator>OLESEN, Tine Kold</creator><creator>VAN DER MEULEN, Egbert, A</creator><creator>JENSEN, Jens-Kristian Slott</creator><scope>EVB</scope></search><sort><creationdate>20231011</creationdate><title>TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX</title><author>PERSSON, Bo-Eric ; CANTOR, Per ; OLESEN, Tine Kold ; VAN DER MEULEN, Egbert, A ; JENSEN, Jens-Kristian Slott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4257197A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PERSSON, Bo-Eric</creatorcontrib><creatorcontrib>CANTOR, Per</creatorcontrib><creatorcontrib>OLESEN, Tine Kold</creatorcontrib><creatorcontrib>VAN DER MEULEN, Egbert, A</creatorcontrib><creatorcontrib>JENSEN, Jens-Kristian Slott</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PERSSON, Bo-Eric</au><au>CANTOR, Per</au><au>OLESEN, Tine Kold</au><au>VAN DER MEULEN, Egbert, A</au><au>JENSEN, Jens-Kristian Slott</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX</title><date>2023-10-11</date><risdate>2023</risdate><abstract>The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for safely and effectively treating androgen-dependent prostate cancer without causing a testosterone spike and/or other side effect of GnRH agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4257197A2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title TREATMENT OF METASTATIC STAGE PROSTATE CANCER WITH DEGARELIX
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T00%3A58%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PERSSON,%20Bo-Eric&rft.date=2023-10-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4257197A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true